Topics
July/August 2016 | What's New On The Anti-pdgf Front?
An Oral Drug for Treatment of AMD?
The potential for this proposed treatment option could be significant for many patients and their caregivers.
Carl C. Awh, MD
April 30, 2026
Study Links Diabetic Retinopathy Severity to Higher Mortality Risk
Genentech to Highlight Real-World and Pipeline Advances in Ophthalmology at ARVO 2026
April 29, 2026
Zeiss to Showcase AI-Driven Retinal Research and Imaging Advances at ARVO 2026
Ocular Therapeutix Enrolls First Patient in Long-Term SOL-X Trial for Axpaxli in Wet AMD
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
